DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo
Keywords: Delta opioid receptor (DOR); SNC-80; Unfolded protein response (UPR); Anti-parkinsonian effect; Neural protection; Inflammation;